Top Markets
Coin of the day
BG Medicine, Inc. BG Medicine, Inc.

BG Medicine, Inc.

BGMD
Rangering i aksjer #42481
BG Medicine, Inc. is dedicated to the development and commercialization of... BG Medicine, Inc. is dedicated to the development and commercialization of diagnostic products aimed at guiding patient care for individuals in the United States afflicted with heart failure and related conditions. Its product portfolio includes the BGM Galectin-3 Test, an in vitro diagnostic solution that quantifies galectin-3 levels in blood serum or plasma using an enzyme-linked immunosorbent assay (ELISA) on a microtiter plate platform. Additionally, the company provides the CardioSCORE Test, a multi-analyte, biomarker-based blood test designed to assess the short-term risk of atherothrombotic cardiovascular events, such as myocardial infarction (heart attack) and ischemic stroke. BG Medicine maintains licensing, development, and commercialization agreements with major partners like Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc., specifically for automated versions of its galectin-3 test. Furthermore, it has forged a strategic alliance with Abbott Laboratories to jointly develop and market galectin-3 assay kits, along with their corresponding control kits and calibrators. Founded in 2000, the company was initially known as Beyond Genomics, Inc., before rebranding to BG Medicine, Inc. in October 2004. Its corporate headquarters are located in Waltham, Massachusetts.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$1.14K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel BG Medicine, Inc. (BGMD)

Kategori

Historikk for aksjesplitt for BG Medicine, Inc. (BGMD)
Aksjen BG Medicine, Inc. (symbol: BGMD) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 13, 2026.
Én BGMD-aksje kjøpt før Aug 13, 2026 tilsvarer i dag 0 BGMD-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
3 x4
US
3 x20
FR
0 -
JP
6 x20
US
0 -
CH